BioSpace News Archive

BioMidwest

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S.

Device is the smallest, 510(k) cleared coronary balloon in the U.S. market

March 1, 2018
·
5 min read
Deals

Sierra Oncology Announces Proposed Public Offering of Common Stock

Sierra Oncology, Inc. announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering.

March 1, 2018
·
1 min read
Business

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

Kindred Biosciences, Inc. announced financial results for the fourth quarter and full year ended December 31, 2017 and provided updates on its programs.

March 1, 2018
·
8 min read
Business

Nektar Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results

Cash and investments in marketable securities at December 31, 2017 were $353.2 million as compared to $389.1 million at December 31, 2016.

March 1, 2018
·
30 min read
Business

Bristol-Myers Squibb Names José Baselga, M.D., Ph.D. to Board of Directors

Dr. Baselga will serve as a member of Science & Technology Committee of the Board of Directors.

March 1, 2018
·
3 min read
Business

Puma Biotechnology Reports Fourth Quarter and Full Year 2017 Financial Results

The Company reported net revenue from initial sales of NERLYNX of approximately $20.1 million in the fourth quarter and $26.2 million for the full year 2017.

March 1, 2018
·
14 min read
Drug Development

IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington’s Disease

Ionis Pharmaceuticals, Inc. announced the presentation of positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx (RG6042) in people with early stage Huntington’s disease (HD) at the 13th Annual CHDI HD conference.

March 1, 2018
·
4 min read
Business

Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results

Achieve Life Sciences, Inc. highlighted recent accomplishments and announced fourth quarter and year-end 2017 financial results.

March 1, 2018
·
3 min read
Business

Perrigo Company plc Reports Fourth Quarter and Calendar Year 2017 Financial Results

Perrigo Company plc announced results for the fourth quarter and calendar year ended December 31, 2017.

March 1, 2018
·
3 min read
Deals

Aytu BioScience Announces Pricing of $12,000,000 Public Offering

Aytu BioScience, Inc. announced the pricing of an underwritten public offering with expected total gross proceeds of $12,000,000, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

March 1, 2018
·
4 min read